Anticancer Drug Development Guide (Cancer Drug Discovery and Development) by Beverly A. Teicher and Paul A. Andrews provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products. The chapters on phase I, II, and III clinical trials and on novel phase II clinical trial designs for targeted therapies have been significantly updated, along with those on cancer drug development in Europe, working with the NCI, and the FDA's role in cancer drug development and setting requirements for approval.
Book Info
Genzyme Corporation, Framingham, MA. Provides a comprehensive and current survey of the drug discovery and development process. Also offers a step-by-step guide to discovery, testing, FDA regulations, clinical trials, and approval of anticancer drugs. Previous edition: c1997. DNLM: Antineoplastic Agents--standards.
Book Details
Book Info
Genzyme Corporation, Framingham, MA. Provides a comprehensive and current survey of the drug discovery and development process. Also offers a step-by-step guide to discovery, testing, FDA regulations, clinical trials, and approval of anticancer drugs. Previous edition: c1997. DNLM: Antineoplastic Agents--standards.
Book Details
- Hardcover: 430 pages
- Publisher: Humana Press; 1 edition (February 1, 2004)
- Language: English
- ISBN-10: 1588292282
- ISBN-13: 9781588292285
- Product Dimensions: 10.1 x 7.3 x 1.3 inches
- List Price: $164.50
- Price: $132.00
- You Save: $32.50 (20%)
